Celltrion
068270.KS
$149.59
Share price
-1.89%
Change (1 day)
-17.49%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Earnings for Celltrion (068270.KS)
Earnings in 2024 (TTM): S$0.62 Billion
According to Celltrion 's latest financial reports the company's current earnings are S$2.58 Billion. a decrease over its 2023 earnings that were of S$0.67 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Celltrion from 2008 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | S$0.61 B | -8.8% |
| 2023 | S$0.67 B | 6.8% |
| 2022 | S$0.63 B | -21.85% |
| 2021 | S$0.81 B | 10.25% |
| 2020 | S$0.73 B | 65.16% |
| 2019 | S$0.44 B | 16.64% |
| 2018 | S$0.38 B | -33.89% |
| 2017 | S$0.57 B | 106.53% |
| 2016 | S$0.27 B | 25.57% |
| 2015 | S$0.22 B | -6.54% |
| 2014 | S$0.23 B | 47.36% |
| 2013 | S$0.16 B | -33.63% |
| 2012 | S$0.24 B | |
| 2010 | S$0.12 B | 72.84% |
| 2009 | S$73.11 M | 260.54% |
| 2008 | S$20.27 M |